Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 7916.45 | 578 / 578 | 100% | 100.24 | 1153 / 1155 |
stomach | 100% | 2924.15 | 358 / 359 | 100% | 102.02 | 286 / 286 |
esophagus | 100% | 3255.79 | 1442 / 1445 | 99% | 74.67 | 182 / 183 |
breast | 100% | 5896.50 | 459 / 459 | 99% | 127.05 | 1109 / 1118 |
intestine | 100% | 3773.29 | 966 / 966 | 99% | 98.50 | 522 / 527 |
brain | 99% | 2566.55 | 2616 / 2642 | 100% | 114.49 | 704 / 705 |
uterus | 100% | 2840.86 | 170 / 170 | 99% | 105.84 | 453 / 459 |
prostate | 100% | 2590.10 | 244 / 245 | 98% | 67.99 | 494 / 502 |
skin | 100% | 3786.72 | 1808 / 1809 | 97% | 135.89 | 458 / 472 |
ovary | 98% | 2030.72 | 177 / 180 | 99% | 92.01 | 424 / 430 |
liver | 100% | 5048.16 | 226 / 226 | 97% | 88.14 | 393 / 406 |
thymus | 100% | 3866.98 | 652 / 653 | 97% | 71.71 | 585 / 605 |
kidney | 100% | 6157.84 | 89 / 89 | 96% | 86.89 | 867 / 901 |
bladder | 100% | 3562.95 | 21 / 21 | 96% | 87.83 | 484 / 504 |
pancreas | 90% | 1374.46 | 296 / 328 | 98% | 86.04 | 175 / 178 |
adrenal gland | 100% | 4724.88 | 258 / 258 | 83% | 42.96 | 190 / 230 |
adipose | 100% | 6971.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 238.13 | 29 / 29 |
muscle | 100% | 3604.45 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6136.82 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 146.49 | 45 / 45 |
blood vessel | 100% | 3661.69 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3095.93 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 5236.94 | 835 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 68% | 43.30 | 54 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006508 | Biological process | proteolysis |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005925 | Cellular component | focal adhesion |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0030145 | Molecular function | manganese ion binding |
GO_0008233 | Molecular function | peptidase activity |
GO_0008235 | Molecular function | metalloexopeptidase activity |
GO_0004180 | Molecular function | carboxypeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0070006 | Molecular function | metalloaminopeptidase activity |
GO_0004177 | Molecular function | aminopeptidase activity |
Gene name | LAP3 |
Protein name | Leucine aminopeptidase 3 Cytosol aminopeptidase (EC 3.4.11.1) (Cysteinylglycine-S-conjugate dipeptidase) (EC 3.4.13.23) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase) |
Synonyms | PEPS LAPEP |
Description | FUNCTION: Cytosolic metallopeptidase that catalyzes the removal of unsubstituted N-terminal hydrophobic amino acids from various peptides. The presence of Zn(2+) ions is essential for the peptidase activity, and the association with other cofactors can modulate the substrate spectificity of the enzyme. For instance, in the presence of Mn(2+), it displays a specific Cys-Gly hydrolyzing activity of Cys-Gly-S-conjugates. Involved in the metabolism of glutathione and in the degradation of glutathione S-conjugates, which may play a role in the control of the cell redox status. . |
Accessions | ENST00000606142.5 [P28838-2] P28838 ENST00000226299.9 [P28838-1] ENST00000513105.1 H0Y9Q1 ENST00000618908.4 [P28838-1] |